Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7415088 | 0.75 | ALDH1A1 (0.33) | MAPTKDM4EMEN1ALDH1A1KMT2A | |
| SCHEMBL28294007 | 0.73 | MAPT (0.34) | ACHEMAPTKDM4EMEN1ALDH1A1 | |
| SCHEMBL9185130 | 0.73 | MAPT (0.34) | ACHEMAPTKDM4EMEN1ALDH1A1 | |
| SCHEMBL25112085 | 0.61 | ACHE (0.41) | ACHEALDH1A1L3MBTL1 | |
| SCHEMBL2821364 | 0.61 | MAPT (0.52) | MAPTKDM4EALDH1A1KMT2A | |
| SCHEMBL9177075 | 0.59 | KMT2A (0.41) | ACHEMAPTKDM4EMEN1ALDH1A1 | |
| SCHEMBL17733568 | 0.59 | CYP1A2 (0.39) | MEN1ALDH1A1KMT2A | |
| SCHEMBL3853426 | 0.57 | AHR (0.39) | ACHEMAPTKDM4EMEN1ALDH1A1 | |
| 1,2-Dichlorobenzene SCHEMBL2922912 | 0.56 | TSHR (0.62) | ALDH1A1 | |
| SCHEMBL15109080 | 0.55 | TSHR (0.45) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109715159-A | Anticancer medicine composition | 国立癌症中心 | 2019-05-03 | — | — | CN | claimed |
| CN-109715607-A | Compounds that inhibit the formation of the C-MYC/MAX/DNA complex | 国立癌症中心 | 2019-05-03 | — | — | CN | claimed |